Mannkind’s Ceo Castagna Squanders An Opportunity To End Share Price Erosion

Wine brand

During the JMP conference, CEO Castagna discussed at length inhalable insulin Afrezza’s attributes while providing virtually no concrete pipeline guidance. Mana


more on seekingalpha.com